Literature DB >> 23038789

Time from emerging heart failure symptoms to cardiac resynchronisation therapy: impact on clinical response.

Frederik Hendrik Verbrugge1, Matthias Dupont, Jan Vercammen, Linda Jacobs, David Verhaert, Pieter Vandervoort, W H Wilson Tang, Wilfried Mullens.   

Abstract

OBJECTIVE: To investigate whether time from onset of heart failure signs and/or symptoms (ie, progression to stage C/D heart failure) until implantation affects reverse remodelling and clinical outcome after cardiac resynchronisation therapy (CRT).
DESIGN: Cohort study of consecutive CRT patients, implanted between 1 October 2008 and 30 April 2011.
SETTING: Single tertiary care centre (Ziekenhuis Oost-Limburg, Genk, Belgium). PATIENTS: Consecutive CRT patients (n=172; 71±9 years), stratified into tertiles according to the time since first heart failure signs and/or symptoms at implantation. MAIN OUTCOME MEASURES: Change in left ventricular dimensions, New York Heart Association (NYHA) functional class and freedom from all-cause mortality or heart failure admission.
RESULTS: Baseline renal function was better in patients implanted earlier after emerging heart failure symptoms (estimated glomerular filtration rate=73±20 vs 63±23 vs 58±26 ml/min/1.73 m(2) for tertiles, respectively). After 6 months, decreases in left ventricular end-diastolic/systolic diameter and improvement in NYHA functional class were similar among tertiles. Freedom from all-cause mortality or heart failure admission was better in patients with early implantation (p value=0.042). However, this was not the case in patients with preserved renal function (p value=0.794). Death from progressive heart failure was significantly more frequent in patients implanted later in their disease course.
CONCLUSIONS: Reverse left ventricular remodelling after CRT is not affected by the duration of heart failure. However, clinical outcome is better in patients implanted earlier in their disease course, which probably relates to better renal preservation.

Entities:  

Mesh:

Year:  2012        PMID: 23038789     DOI: 10.1136/heartjnl-2012-302807

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  3 in total

1.  Spirituality: A Panacea for Patients Coping with Heart Failure.

Authors:  Parvin Mangolian Shahrbabaki; Esmat Nouhi; Majid Kazemi; Fazlollah Ahmadi
Journal:  Int J Community Based Nurs Midwifery       Date:  2017-01

2.  Comparison of De Novo versus Upgrade Cardiac Resynchronization Therapy; Focused on the Upgrade for Pacing-Induced Cardiomyopathy.

Authors:  Hye Bin Gwag; Kwang Jin Chun; Jin Kyung Hwang; Kyoung Min Park; Young Keun On; June Soo Kim; Seung Jung Park
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

Review 3.  'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor.

Authors:  Amr Abdin; Stefan D Anker; Javed Butler; Andrew J Stewart Coats; Ingrid Kindermann; Mitja Lainscak; Lars H Lund; Marco Metra; Wilfried Mullens; Giuseppe Rosano; Jonathan Slawik; Jan Wintrich; Michael Böhm
Journal:  ESC Heart Fail       Date:  2021-10-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.